Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06158958
Title A Study of Adverse Events, How Intravenously (IV) Infused ABBV-303 Moves Through the Body, and Change in Disease State, as Monotherapy and in Combination With IV Infused Budigalimab (ABBV-181), in Adult Participants With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors AbbVie
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
START Midwest /ID# 256945 RECRUITING Grand Rapids Michigan 49546-7062 United States Details
Carolina BioOncology Institute /ID# 254305 RECRUITING Huntersville North Carolina 28078 United States Details
University of Texas MD Anderson Cancer Center /ID# 254308 RECRUITING Houston Texas 77030 United States Details
NEXT Oncology /ID# 257395 RECRUITING San Antonio Texas 78229 United States Details
South Texas Accelerated Research Therapeutics /ID# 256944 RECRUITING San Antonio Texas 78229 United States Details
Rambam Health Care Campus /ID# 254608 RECRUITING Haifa H_efa 3109601 Israel Details
The Chaim Sheba Medical Center /ID# 259408 RECRUITING Ramat Gan Tel-Aviv 5265601 Israel Details
Hadassah Medical Center /ID# 254606 RECRUITING Jerusalem Yerushalayim 9112001 Israel Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field